Cargando…

Multiple 17-OHP Cutoff Co-Variates Fail to Improve 21-Hydroxylase Deficiency Screening Accuracy

To improve the positive predictive value (PPV) of newborn screening for 21-hydroxylase deficiency (21OHD), co-variates have been used to modify 17-hydroxyprogesterone (17OHP) cutoffs. The objective of this study is to evaluate whether 17OHP screening cutoffs adjusted for both collection time (CT) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matharu, Preet K., Held, Patrice K., Allen, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680344/ https://www.ncbi.nlm.nih.gov/pubmed/36412583 http://dx.doi.org/10.3390/ijns8040057

Ejemplares similares

SAT-098 The Impact of 17-OHP Cutoffs Determination in a Public Newborn Screening Program for Congenital Adrenal Hyperplasia in Southern Brazil: A Three Years’ Experience
por: Kopacek, Cristiane, et al.
Publicado: (2020)

Children with premature pubarche: is an alterated neonatal 17-Ohp screening test a predictive factor?
por: Cavarzere, Paolo, et al.
Publicado: (2018)

Hypersensitivity reactions related to oxaliplatin (OHP)
por: Brandi, G, et al.
Publicado: (2003)

21-Hydroxylase Deficiency: Newborn Screening in Iran?
por: Mahdieh, Nejat, et al.
Publicado: (2012)

Neonatal mass screening for 21-hydroxylase deficiency
por: Tajima, Toshihiro, et al.
Publicado: (2016)

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2022)

Variation in serum adrenal hormones in female 21-hydroxylase deficient patients
por: Sørensen, Ditte Sofie Dahl, et al.
Publicado: (2022)

OHP: An Online Histogram Presenter for the ATLAS experiment
por: Dotti, Andrea, et al.
Publicado: (2006)

Study relationship between the value of 17-OHP and the value of testosterone in monitoring for congenital adrenal hyperplasia
por: Huong, Ngo Thi Thu, et al.
Publicado: (2013)

The GNAM monitoring system and the OHP histogram presenter for ATLAS
por: Zema, P F, et al.
Publicado: (2005)

GNAM and OHP: Monitoring Tools for ATLAS experiment at LHC.
por: Adragna, P, et al.
Publicado: (2007)

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2020)

POR polymorphisms are associated with 21 hydroxylase deficiency
por: Pecori Giraldi, F., et al.
Publicado: (2021)

High-Dose Hook Effect in 17-Hydroxyprogesterone Assay in a Patient with 21-Hydroxylase Deficiency
por: Parlak, Mesut, et al.
Publicado: (2015)

A case of 17 alpha-hydroxylase deficiency
por: Kim, Sung Mee, et al.
Publicado: (2015)

The prevalence and genotype of 21-hydroxylase deficiency in the Croatian Romani population
por: Dumic, Katja K., et al.
Publicado: (2023)

Oxaliplatin (L-OHP): a new reality in colorectal cancer.
por: Bleiberg, H.
Publicado: (1998)

Trialling of an optimal health programme (OHP) across chronic disease
por: Ski, Chantal F., et al.
Publicado: (2016)

Two Adults with Adrenal Myelolipoma and 21-Hydroxylase Deficiency
por: Nermoen, Ingrid, et al.
Publicado: (2009)

Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
por: Ventura, Annamaria, et al.
Publicado: (2013)

Prenatal Diagnosis and Treatment of Steroid 21-Hydroxylase Deficiency
por: Tajima, Toshihiro, et al.
Publicado: (2008)

Monitoring treatment in pediatric patients with 21-hydroxylase deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2023)

Genotype-phenotype correlation in patients with 21-hydroxylase deficiency
por: Tang, Peng, et al.
Publicado: (2023)

New insights on hyperglycemia in 17-hydroxylase/17,20-lyase deficiency
por: Xu, Lingling, et al.
Publicado: (2022)

Neonatal Screening and Genotype-Phenotype Correlation of 21-Hydroxylase Deficiency in the Chinese Population
por: Wang, Xin, et al.
Publicado: (2021)

Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe
por: Nowotny, Hanna, et al.
Publicado: (2022)

Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Lee, Peter A., et al.
Publicado: (2010)

Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
por: Ishii, Tomohiro, et al.
Publicado: (2015)

Health problems of adolescent and adult patients with 21-hydroxylase deficiency
por: Tajima, Toshihiro
Publicado: (2018)

The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2019)

Pregnancy outcomes in in vitro fertilization in 17-alpha-hydroxylase deficiency
por: van Oosbree, Annika, et al.
Publicado: (2023)

Compliance Issues in Managing 21 Hydroxylase Deficiency and their Short/Long-Term Consequences
por: Lin, Jack, et al.
Publicado: (2021)

Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
por: Dörr, Helmuth G., et al.
Publicado: (2019)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020)

Salidroside could enhance the cytotoxic effect of L-OHP on colorectal cancer cells
por: Shi, Xiaoming, et al.
Publicado: (2018)

Odor Hedonic Profile (OHP): a self-rating tool of everyday odors
por: Charlotte, Bontempi, et al.
Publicado: (2023)

Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia
por: Kolahdouz, Mahsa, et al.
Publicado: (2015)

Corrigendum: The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2020)

Huge ovarian cyst in a neonate with classical 21-hydroxylase deficiency
por: Abdelmeguid, Yasmine, et al.
Publicado: (2021)

Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach
por: Arriba, María, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hgl8l9qpjohklhah8evvl86sc7